These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15611277)

  • 1. SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels.
    Gimborn K; Lessmann E; Kuppig S; Krystal G; Huber M
    J Immunol; 2005 Jan; 174(1):507-16. PubMed ID: 15611277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell activation is differentially affected by heat shock.
    Mortaz E; Redegeld FA; van der Heijden MW; Wong HR; Nijkamp FP; Engels F
    Exp Hematol; 2005 Aug; 33(8):944-52. PubMed ID: 16038788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective degranulation and calcium mobilization of bone-marrow derived mast cells from Xid and Btk-deficient mice.
    Setoguchi R; Kinashi T; Sagara H; Hirosawa K; Takatsu K
    Immunol Lett; 1998 Dec; 64(2-3):109-18. PubMed ID: 9870661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes.
    Kepley CL; Taghavi S; Mackay G; Zhu D; Morel PA; Zhang K; Ryan JJ; Satin LS; Zhang M; Pandolfi PP; Saxon A
    J Biol Chem; 2004 Aug; 279(34):35139-49. PubMed ID: 15151996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Fc epsilon RI-mediated signal strength plays a key role in regulating basophil signaling and deactivation.
    Gibbs BF; Räthling A; Zillikens D; Huber M; Haas H
    J Allergy Clin Immunol; 2006 Nov; 118(5):1060-7. PubMed ID: 17088130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity.
    Kalesnikoff J; Baur N; Leitges M; Hughes MR; Damen JE; Huber M; Krystal G
    J Immunol; 2002 May; 168(9):4737-46. PubMed ID: 11971024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of SHIP in mast cell degranulation and IgE-induced mast cell survival.
    Huber M; Kalesnikoff J; Reth M; Krystal G
    Immunol Lett; 2002 Jun; 82(1-2):17-21. PubMed ID: 12008029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of SHIP in the development and activation of mouse mucosal and connective tissue mast cells.
    Ruschmann J; Antignano F; Lam V; Snyder K; Kim C; Essak M; Zhang A; Lin AH; Mali RS; Kapur R; Krystal G
    J Immunol; 2012 Apr; 188(8):3839-50. PubMed ID: 22430739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulus strength determines the BTK-dependence of the SHIP1-deficient phenotype in IgE/antigen-triggered mast cells.
    Zorn CN; Simonowski A; Huber M
    Sci Rep; 2018 Oct; 8(1):15467. PubMed ID: 30341350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inositol 5'-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production.
    Leung WH; Bolland S
    J Immunol; 2007 Jul; 179(1):95-102. PubMed ID: 17579026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
    Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
    J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation.
    Huber M; Helgason CD; Damen JE; Liu L; Humphries RK; Krystal G
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11330-5. PubMed ID: 9736736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired signaling via the high-affinity IgE receptor in Wiskott-Aldrich syndrome protein-deficient mast cells.
    Pivniouk VI; Snapper SB; Kettner A; Alenius H; Laouini D; Falet H; Hartwig J; Alt FW; Geha RS
    Int Immunol; 2003 Dec; 15(12):1431-40. PubMed ID: 14645152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
    Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
    Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C-delta is a negative regulator of antigen-induced mast cell degranulation.
    Leitges M; Gimborn K; Elis W; Kalesnikoff J; Hughes MR; Krystal G; Huber M
    Mol Cell Biol; 2002 Jun; 22(12):3970-80. PubMed ID: 12024011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling.
    Ott VL; Tamir I; Niki M; Pandolfi PP; Cambier JC
    J Immunol; 2002 May; 168(9):4430-9. PubMed ID: 11970986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
    Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
    J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionality of the IgA Fc receptor (FcalphaR, CD89) is down-regulated by extensive engagement of FcepsilonRI.
    Matsui T; Nunomura S; Shimokawa T; Yoshimaru T; Ra C
    Clin Immunol; 2008 Oct; 129(1):155-62. PubMed ID: 18700185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scaffold protein prohibitin is required for antigen-stimulated signaling in mast cells.
    Kim DK; Kim HS; Kim AR; Jang GH; Kim HW; Park YH; Kim B; Park YM; Beaven MA; Kim YM; Choi WS
    Sci Signal; 2013 Sep; 6(292):ra80. PubMed ID: 24023254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHIP represses mast cell activation and reveals that IgE alone triggers signaling pathways which enhance normal mast cell survival.
    Kalesnikoff J; Lam V; Krystal G
    Mol Immunol; 2002 Sep; 38(16-18):1201-6. PubMed ID: 12217384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.